INIS
transplants
100%
mice
84%
tolerance
79%
kidneys
52%
grafts
43%
death
39%
ligands
36%
induction
34%
diseases
32%
regulations
30%
doses
28%
therapy
27%
molecules
26%
inflammation
24%
data
24%
antibodies
22%
humans
21%
receptors
19%
patients
19%
organs
19%
comparative evaluations
18%
injuries
18%
conversion
17%
production
17%
ischemia
16%
globulins
15%
proteins
15%
steroids
15%
bone marrow
14%
cytokines
14%
in vivo
13%
antigens
13%
tyrosine
12%
genes
12%
immunity
12%
pancreas
11%
monoclonal antibodies
11%
control
11%
levels
11%
expansion
11%
clinical trials
10%
rabbits
10%
blocking
10%
proliferation
10%
signals
10%
tissues
10%
reviews
10%
tumors
10%
thymocytes
9%
transferases
9%
Medicine and Dentistry
Transplantation
70%
T Cell
65%
Cells
41%
Regulatory Mechanism
34%
Allograft
33%
Kidney Graft
33%
Autoimmunity
32%
Donor
32%
Regulatory T Cell
32%
Graft Rejection
29%
Diabetes
26%
Combination Therapy
25%
T-Helper Cell
21%
NOD Mice
21%
Therapeutic Procedure
21%
Tacrolimus
21%
Autoimmune Diabetes
21%
Transplantation Tolerance
21%
Diseases
20%
Insulin Dependent Diabetes Mellitus
20%
Development
20%
Low Drug Dose
19%
Alloimmunity
17%
Exhaustion
17%
Ischemic Injury
17%
Graft Survival
17%
Cardiac Allograft Vasculopathy
17%
Abatacept
16%
Calcineurin Inhibitor
16%
Steroid
15%
Diabetes Mellitus
15%
Thymocyte Antibody
14%
Death
14%
Kidney
13%
Ligand
13%
Rapamycin
13%
Human
12%
CD8 Antigen
11%
Immunosuppressive Drug
10%
Organ Transplantation
10%
Cytotoxic T-Cell
10%
Programmed Death 1 Ligand 1
10%
Patient
10%
Allograft Vasculopathy
10%
Belatacept
9%
B Cell
9%
Ex Vivo
9%
Immune Response
9%
Gene
9%
Leukocyte Recruitment
9%
Immunology and Microbiology
Transplantation
92%
Regulatory T Cell
41%
Cells
36%
Allotransplantation
32%
CD4
31%
Kidney
29%
Regulatory Mechanism
25%
Development
24%
Transplant Rejection
23%
Mouse
22%
Tacrolimus
21%
Transplantation Tolerance
21%
Survival
20%
Nonobese Diabetic Mouse
19%
Low Drug Dose
18%
Molecule
18%
Intravenous Immunoglobulin
17%
Immunity
17%
CD8
15%
Autoimmunity
15%
CD28
14%
Abatacept
14%
Mycophenolic Acid
14%
Inflammation
13%
Gene
13%
Allograft Vasculopathy
12%
Organ
12%
Dose
11%
B Cell
11%
Immunity
11%
Interleukin 17
10%
Programmed Death 1 Ligand 1
10%
Monospecific Antibody
10%
MHC Class II
9%
Sirolimus
9%
Immune Response
9%
Belatacept
9%
CD154
9%
Autoimmune Diabetes
9%
Monoclonal Antibodies
9%
Th17 Cell
9%
Autoimmune Disease
8%
Aptitude
8%
Human
8%
Memory B Cell
7%
CD160
7%
CXC Chemokine Receptors
7%
Everolimus
7%
BioBreeding Rat
7%
Selectin
7%